Advertisement

Changes in cognition and brain function following 26 weeks of progressive resistance training in older adults at risk for diabetes: A pilot randomized controlled trial

Published:January 12, 2023DOI:https://doi.org/10.1016/j.jcjd.2023.01.004
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Introduction

      Type 2 diabetes is associated with deficits in cognition and brain health. Individuals with 1 or more risk factors for diabetes (i.e., obesity, prediabetes) already experience some neurocognitive impairment and are at risk for further decline. One way to combat these deficits is through exercise; however, whether resistance exercise can improve these functions in this at-risk group is unknown.

      Methods

      This study was a pilot randomized controlled trial. Participants were aged 60-80 and had prediabetes (fasting capillary glucose 6.1-6.9 mmol/L) and/or were overweight or obese (body mass index of 25 or above). Participants completed resistance training or balance and stretching exercise (control) thrice-weekly for 6 months. Neuropsychological tests were used to assess cognitive ability, while functional magnetic resonance imaging was used to examine brain activation patterns.

      Results

      Resistance training led to improvements in task-switching, attention, and conflict resolution, as well as improved patterns of brain activation that may mimic healthy older adults.

      Conclusions

      Resistance exercise may serve as an effective behavioural strategy to improve neurocognition in older adults at risk for type 2 diabetes. A large-scale powered trial is needed to further explore these findings.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect